SHANGHAI, China, March 24 /Xinhua-PRNewswire/ -- WuXi PharmaTech, a leading provider of the pharmaceutical R&D services in China, recently announced it has signed a license agreement with Thermo Watson, a world leader in analytical instruments to implement its Laboratory Information Management System (LIMS). As the first and the only drug R&D Company adopting the Watson LIMS System in China by now, WuXi PharmaTech has been equipped with an integrated solution to meet its specific data management requirements for its bioanalytical facility operations.
(Logo: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGO )
The Watson LIMS system is specifically designed to support and follow the process of the bioanalytical laboratory, and has been developed to promote compliance with GLP regulations and the FDA 21 CFR Part 11 guidance. As a de facto industry standard, the system is installed in 18 of the top 20 global pharmaceutical organizations, and is widely used in leading biotechnology and contract research organizations worldwide.
''The most recent agreement with Thermo Watson catapults our bioanalytical service group to the globally accepted quality level,’' Dr. Ge Li, Chairman and CEO of WuXi PharmaTech said, ''Using the Watson LIMS system will significantly accelerate our analysis and laboratory turnaround, reduce costs associated with sample management and increase workflow efficiency. It will substantially provide WuXi PharmaTech in the bioanalytical services with an integrated solution to bring high quality services to our clients.’'
About WuXi PharmaTech
Founded in 2001, the Shanghai-based WuXi PharmaTech Co., Ltd., is the leader in the pharmaceutical R&D services industry in China. WuXi PharmaTech assists global pharmaceutical and biopharmaceutical companies in shortening the cycle and lowering the cost of drug research and development, and helps clients fully leverage the lower cost R&D capacity in China.
As an integrated drug R&D outsourcing service company, WuXi PharmaTech provides discovery and development services to our partners from lead identification to pre-clinical through our state-of-the-art facilities. The company has a broad service spectrum ranging from lead generation and optimization, in vivo and in vitro ADMET profiling, bioanalytical services, to chemistry process development and large scale manufacturing. There are over 750 scientific staff members and its management team consists of veterans from U.S., India and Japan pharmaceutical industry. WuXi PharmaTech has a 360,000 sq. ft. state-of-the-art research center in WaiGaoQiao Free Trade Zone and a 250,000 sq. ft. and ISO 9001:2000 certified GMP plant in Jinshan Chemical Industry Development Zone, Shanghai. The company’s customers include 19 of the top 20 pharmaceutical companies and 8 of the top 10 biopharmaceutical companies in the world.
About Thermo Electron
Thermo Electron Corporation is the world leader in analytical instruments. Our instrument solutions enable our customers to make the world a healthier, cleaner and safer place. Thermo’s Life and Laboratory Sciences segment provides analytical instruments, scientific equipment, services and software solutions for life science, drug discovery, clinical, environmental and industrial laboratories. Thermo’s Measurement and Control segment is dedicated to providing analytical instruments used in a variety of manufacturing processes and in-the-field applications, including those associated with safety and homeland security. Based near Boston, Massachusetts, Thermo has revenues of approximately $2.7 billion, and employs approximately 11,000 people in 30 countries. For more information, visit http://www.thermo.com .
For more information, please contact: David Yin WuXi PharmaTech, Public Relations Tel: +86-21-5046-4003 Email: yin_xiaojun@pharmatechs.com
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20040705/CNM002LOGOAP Archive: http://photoarchive.ap.orgPRN Photo Desk, +1-888-776-6555 or +1-212-782-2840WuXi PharmaTech Co., Ltd.
CONTACT: David Yin, Public Relations of WuXi PharmaTech, +86-21-5046-4003,or yin_xiaojun@pharmatechs.com
Web site: http://www.thermo.com/
